+41.1%
GSK vs AEIS
+113.2%
-72.0%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | AEIS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -10.4% | +10.3% | 0.0% |
| 7D | -5.3% | -13.4% | +8.1% | -5.2% |
| 30D | -3.7% | -23.2% | +19.5% | -3.5% |
| 3M | -7.3% | -35.0% | +27.7% | -6.8% |
| 6M | -4.2% | -39.2% | +35.0% | -4.1% |
| YTD | +0.9% | -9.1% | +9.9% | -1.2% |
| 1Y | +7.3% | +0.8% | +6.4% | +4.5% |
| 3Y | +52.7% | +97.8% | -45.0% | +41.5% |
| All | +41.1% | +113.2% | -72.0% | +25.9% |
Cumulative growth
Daily Returns
Daily percentage return beside AEIS.
Daily Out/Under-Performance
Portfolio return minus AEIS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AEIS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded AEIS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling